Literature DB >> 1269093

Mitochondrial structure and function in acute myocardial ischemic injury.

R B Jennings, C E Ganote.   

Abstract

Changes in both the structure and function of mitochondria occur in the dog heart as a consequence of severe ischemia produced by acute coronary occlusion. Brief periods of severe ischemia (reversible injury) produced no significant change in mitochondrial ultrastructure and no defects in pyruvate or succinate metabolism. However, periods of ischemia of 40-60 minutes' duration (irreversible injury) produced striking structural changes including swelling, an increase in matrix space, disorganization of cristae, and the appearance of amorphous matrix densities. After 60 minutes of severe ischemia, one or more amorphous densities were present in each mitochondrial profile. These osmiophilic structures contained lipid but have not been characterized further. Their presence was typical of the irreversible state. Mitochondria of irreversibly injured cells were fragile, and consequently were more difficult to isolate than mitochondria of control tissue. Furthermore, after isolation from tissue injured by 60 minutes of ischemia, they showed markedly defective function.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269093

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  45 in total

1.  Heat stress contributes to the enhancement of cardiac mitochondrial complex activity.

Authors:  I A Sammut; J Jayakumar; N Latif; S Rothery; N J Severs; R T Smolenski; T E Bates; M H Yacoub
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

Review 2.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury.

Authors:  Nina Kaludercic; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Nazareno Paolocci
Journal:  Biochim Biophys Acta       Date:  2010-09-24

3.  Protective activity of nifedipine and R 58735 upon damage caused by global ischemia in the guinea pig heart-lung preparation.

Authors:  H W Boddeke; T J Jap; J G Hugtenburg; J B Heynis; R D Veldsema-Currie; B Wilffert; P A van Zwieten
Journal:  Basic Res Cardiol       Date:  1989 Sep-Oct       Impact factor: 17.165

Review 4.  Mitochondria and cardioprotection.

Authors:  Fabio Di Lisa; Marcella Canton; Roberta Menabò; Nina Kaludercic; Paolo Bernardi
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 5.  MitoKATP activity in healthy and ischemic hearts.

Authors:  Alexandre D T Costa; Keith D Garlid
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

6.  Clinical experience of coenzyme Q10 to enhance intraoperative myocardial protection in coronary artery revascularization.

Authors:  M Sunamori; H Tanaka; T Maruyama; I Sultan; T Sakamoto; A Suzuki
Journal:  Cardiovasc Drugs Ther       Date:  1991-03       Impact factor: 3.727

Review 7.  Cardioprotective signaling to mitochondria.

Authors:  Keith D Garlid; Alexandre D T Costa; Casey L Quinlan; Sandrine V Pierre; Pierre Dos Santos
Journal:  J Mol Cell Cardiol       Date:  2008-12-11       Impact factor: 5.000

8.  Cryopreservation: An emerging paradigm change.

Authors:  John G Baust; Dayong Gao; John M Baust
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

9.  Myocardial ischaemia inhibits mitochondrial metabolism of 4-hydroxy-trans-2-nonenal.

Authors:  Bradford G Hill; Sunday O Awe; Elena Vladykovskaya; Yonis Ahmed; Si-Qi Liu; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Biochem J       Date:  2009-01-15       Impact factor: 3.857

Review 10.  Calcium antagonists: definition and mode of action.

Authors:  W G Nayler; P Poole-Wilson
Journal:  Basic Res Cardiol       Date:  1981 Jan-Feb       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.